METHYLIN 10 mg Chewable Tablet
RxNorm 1091153
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1091153 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: METHYLIN 10 mg Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSN
Prescribable Name (PSN):
METHYLIN 10 mg Chewable Tablet
(Atom ID: 6367690)
SY
Synonym (SY):
Methylin 10 mg Chewable Tablet
(Atom ID: 2258693)
SBD
Semantic Branded Drug (SBD):
Methylphenidate hydrochloride 10 mg Chewable Tablet [Methylin]
(Atom ID: 12367513)
Patient Education
Methylphenidate
Methylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Methylphenidate (Methylin) is also used to treat narcolepsy (a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep). Methylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by changing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.